CONCLUSION: brimonidine made domestically is effective and safe in reducing IOP of POAG and OHT, possessing equivalent efficacy with brimonidine imported.
AIM: To investigate the therapeutic value of domestic brimonidine in treating patients with primary open Angle glaucoma (POAG) or ocular hypertension (OHT).
目的:验证国产溴莫尼定滴眼液治疗原发性开角型青光眼和高眼压症的治疗价值。
3
ObjectiveTo compare the effects of two antiglaucoma drugs( levobunlol and brimonidine) on cultured human non-pigment ciliary epithelial (NPE) cells and evaluate the safety of the two drugs.